4 results match your criteria: "Sotiria General Hospital Athens School of Medicine[Affiliation]"
COVID-19 and Thrombotic or Thromboembolic Disease: Implications for Prevention, Antithrombotic Therapy, and Follow-Up: JACC State-of-the-Art Review.
J Am Coll Cardiol
June 2020
Liverpool Centre for Cardiovascular Science, Liverpool Heart and Chest Hospital, University of Liverpool, Liverpool, United Kingdom; Aalborg University, Aalborg, Denmark.
Article Synopsis
- * Patients with existing thrombotic issues may face challenges when they contract COVID-19, affecting how their blood-thinning treatments are managed.
- * The authors discuss the importance of using technology to help treat not only COVID-19 patients but also those with thrombotic diseases during the pandemic.
Khorana Score: Νew Predictor of Early Mortality in Patients With Lung Adenocarcinoma.
Clin Appl Thromb Hemost
November 2018
1 Oncology Unit GPP, Sotiria General Hospital Athens School of Medicine, Athens, Greece.
Venous thromboembolism (VTE) is a typical complication in patients with lung cancer. Khorana score is an established tool for thromboembolic risk stratification of ambulatory patients with cancer undergoing outpatient chemotherapy. The aim of this study was to evaluate the predictive value of the Khorana score for VTE and death in patients with lung adenocarcinoma during first-line or adjuvant chemotherapy.
View Article and Find Full Text PDFThe Role of Tinzaparin in Oncology.
Clin Appl Thromb Hemost
July 2018
1 Oncology Unit GPP, Sotiria General Hospital Athens School of Medicine, Athens, Greece.
Current guidelines recommend low-molecular-weight heparin treatment in patients with cancer with established venous thromboembolism (VTE). The aim of this article was to study the pharmacological properties and effectiveness of tinzaparin in patients with cancer as well as its potential anticancer properties. A search of PubMed and ScienceDirect databases up to March 2016 was carried out to identify published studies that detect the properties and use of tinzaparin in oncology.
View Article and Find Full Text PDFVenous Thromboembolism in Patients Diagnosed With Lung Cancer.
Angiology
September 2016
Oncology Unit GPP, Sotiria General Hospital Athens School of Medicine, Athens, Greece Yale School of Medicine, New Haven, CT, USA.
Purpose: Considering the high prevalence of lung cancer, our purpose was to summarize the existing literature to identify the several factors that contribute to the increased risk of venous thromboembolism (VTE) in patients with lung cancer and to analyze the current recommendations for thromboprophylaxis and treatment of VTE in those patients.
Methods: We searched the Medline and EMBASE databases from February 1985 to February 2014 to identify retrospective and prospective randomized controlled studies that investigate one or more risk factors for VTEs in patients with lung cancer.
Results: A VTE is a major complication for patients diagnosed with lung cancer.